Stay updated on Pyrotinib Maleate in HER2-Positive Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the Pyrotinib Maleate in HER2-Positive Solid Tumors Clinical Trial page.

Latest updates to the Pyrotinib Maleate in HER2-Positive Solid Tumors Clinical Trial page
- Check5 days agoChange DetectedA new revision entry (v3.6.2) was added to the study record history, and the previous revision (v3.6.0) was removed. This reflects an update to the documentation of the page's history.SummaryDifference0.1%

- Check12 days agoNo Change Detected
- Check19 days agoChange DetectedThe record history now shows explicit 'Last verified' and 'Last known status was' with a new 'Revision: v3.6.0', replacing the previous labels and the older revision 'v3.5.5'.SummaryDifference3%

- Check26 days agoChange DetectedThe study history shows a new revision entry (v3.5.5) and the previous revision (v3.5.4) is removed from the history list, updating the visible record of changes.SummaryDifference0.1%

- Check47 days agoChange DetectedAdded a new Revision: v3.5.4 entry to the Study Record History, replacing the previous Revision: v3.5.3 entry and indicating an update to the page's version history.SummaryDifference0.1%

- Check68 days agoChange DetectedThis update reflects a revision/version bump on the ClinicalTrials.gov page (v3.5.0 → v3.5.3), with no accompanying changes to the displayed study record history content.SummaryDifference0.1%

- Check105 days agoChange DetectedAddition of Revision v3.5.0 and deletion of Revision v3.4.3 in the record history.SummaryDifference0.1%

Stay in the know with updates to Pyrotinib Maleate in HER2-Positive Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pyrotinib Maleate in HER2-Positive Solid Tumors Clinical Trial page.